VMS Asset Management

Total investments

35

Average round size

196M

Portfolio companies

34

Rounds per year

1.94

Lead investments

6

Follow on index

0.03

Exits

13

Stages of investment
Private Equity
Areas of investment
BiotechnologyE-CommerceInternetFinTechHealth CareHealth DiagnosticsBig DataMedical DeviceMedicalPharmaceutical

Investments analytics

Analytics

Total investments
35
Lead investments
6
Exits
13
Rounds per year
1.94
Follow on index
0.03
Investments by industry
  • Biotechnology (11)
  • Health Care (9)
  • Pharmaceutical (5)
  • Big Data (5)
  • Internet (4)
  • Show 59 more
Investments by region
  • China (25)
  • United States (6)
  • Taiwan (2)
  • Israel (1)
Peak activity year
2018
Number of Unicorns
8
Number of Decacorns
8
Number of Minotaurs
9

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
11
Avg. valuation at time of investment
989M
Group Appearance index
0.71
Avg. company exit year
16
Avg. multiplicator
2.44
Strategy success index
0.70

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company nameDeal dateIndustryDeal stageDeal sizeLocation
Hope Medicine07 Feb 2024Health Care, MedicalEarly Stage Venture30MJiangsu, Xuanwu District, China
Inmagene Biopharmaceuticals01 Jun 2021Biotechnology, Health Care, BiopharmaLate Stage Venture100MShandong, Zhangdian District, China
Maitao27 Jul 2015TourismEarly Stage Venture6MShanghai, China
Pattern06 Aug 2019Consumer Goods, Retail, LifestyleEarly Stage Venture14MUnited States, New York, New York

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.